Non‑contact low‑frequency ultrasound (NLFU) for wound treatment — Coverage Criteria
This policy governs coverage determinations for non‑contact low‑frequency ultrasound (NLFU) devices used to treat wounds for BlueCHiP for Medicare and Commercial products of Blue Cross Blue Shield of Rhode Island.
No material clinical or coverage changes in this revision.
Coverage Determination
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.